Swiss drugs regulator approves one of Pfizer’s COVID-19 booster shots
Pfizer #Pfizer
BERLIN, Oct 10 (Reuters) – Swiss drugs regulator Swissmedic said on Monday it had temporarily approved Pfizer’s COVID-19 booster shot targeting the original and BA.1 Omicron coronavirus variants.
Swissmedic added that the data currently available to it was not yet sufficient to make a decision on Pfizer’s bivalent booster vaccine targeting the BA.4 and BA.5 Omicron variants.
Register now for FREE unlimited access to Reuters.com Register
Writing by Miranda Murray, editing by Rachel More
Our Standards: The Thomson Reuters Trust Principles.